SETD2 and neoplasm: H3K36me3 is reduced in SETD2-deficient tumor cells, decreasing the recruitment of DNMT3B and the methylation of DNA, increasing interferon immune responses and the expression of transposable elements, therefore improving the sensitivity to DAC.